Strata Critical Medical (SRTA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Strata Critical Medical (SRTA) last issued guidance on August 4, 2026 for fiscal year 2026. The company guided revenue in the range of $285M - $295M for the period.
Compared to prior guidance, Strata Critical Medical raised its revenue forecast from a prior range of $260M - $275M.
Strata Critical Medical has issued 5 guidance updates between November 10, 2025 and August 4, 2026. During this period, the company raised its outlook 3 times, reflecting management's growing confidence in business performance.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.04 | $-0.04 | $-0.04 | $-0.02 |
| Actual | $-0.12 | $0.03 | $-0.06 | $-0.12 |
| Surprise | -200.0% | +175.0% | -50.0% | -500.0% |
| Revenue | ||||
| Estimate | $66.9M | $63.7M | $60.4M | $58.5M |
| Actual | $72.5M | $67.4M | $66.8M | $49.3M |
| Surprise | +8.43% | +5.75% | +10.7% | -15.7% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $0.01 | $0.01 |
| Revenue | ||
| Consensus | $72.8M | $78.1M |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $-0.12 | $-0.04 | -200.0 % |
| Q1 | May 6, 2026 | $0.03 | $-0.04 | 175.0 % |
| Q4 | Mar 3, 2026 | $-0.06 | $-0.04 | -50.0 % |
| Q3 | Nov 10, 2025 | $-0.12 | $-0.02 | -500.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $72.51M | $66.87M | 8.43 % |
| Q1 | May 6, 2026 | $67.38M | $63.72M | 5.75 % |
| Q4 | Mar 3, 2026 | $66.79M | $60.35M | 10.7 % |
| Q3 | Nov 10, 2025 | $49.30M | $58.47M | -15.7 % |